Dawnrays is a Hong Kong-based pharmaceutical enterprise, established in 1995 with the main operations in China. Since July 2003, Dawnrays Pharmaceutical (Holdings) Ltd. has been listed on the Main Board of Hong Kong Stock Exchange Market. Stock code is HK2348.

The group is engaged in the development, manufacturing and marketing of cephalosporin antibiotics, and various specialty drugs (generic drugs). The turnover was 200 million USD in 2009. The product range also covers various pharmaceutical formulations,  including bulk drugs, powder for injection, tablets, capsules, granules and intermediates.It is one of the few third generation Cephalosporins manufacturers in China that are adopting a comprehensive vertically integrated production process. Dawnrays is equipped with advanced production process and techniques, especially our well-known Solvent-crystallization technique in producing Cefoperazone, ceftriaxone,cefoperazone, cefepime sodium sterile The quality has reached the international standard. Dawnrays has been producing the fourth generation cephalosporins and has boosted its production capacity of cephalosporins bulk drug to 800 tons/years. It is expected to become the main producer worldwide.

Dawnrays has been devoting itself to the health of human beings. With the high sense of social responsibility, long business vision, and the continuous effort in technological innovations, Dawnrays continues to contribute to the society by safe and effective drug and achieve to become one of the best pharmaceutical companies worldwide.

Address: 22 Tianling Road, Wuzhong Economic Development District, Suzhou, Jiangsu, 215128, China

Tel: 86-512-65626868      Fax: 86-512-65626969     Email: export@dawnrays.com